Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:58:17 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



News for U:IGC from 2023-05-02 to 2024-05-01 - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-16 07:00U:IGCNews ReleaseIGC-AD1's Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two
2024-04-09 09:00U:IGCNews ReleaseIGC Pharma Adds Advisor in Artificial Intelligence
2024-03-26 15:00U:IGCNews ReleaseIGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
2024-03-20 11:00U:IGCNews ReleaseIGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation
2024-03-20 07:00U:IGCNews ReleaseIGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
2024-03-12 15:00U:IGCNews ReleaseIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer's Pipeline
2024-02-28 13:00U:IGCNews ReleasePromising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
2024-02-23 12:01U:IGCNews ReleaseIGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
2024-02-16 19:05U:IGCNews ReleaseIGC Pharma Reports Third Quarter Fiscal 2024 Results
2024-02-01 09:20U:IGCNews ReleaseIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
2024-01-23 09:20U:IGCNews ReleaseIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer ¢ € ™s
2024-01-17 09:20U:IGCNews ReleaseIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer ¢ € ™s Trial
2023-12-19 09:20U:IGCNews ReleasePatent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer ¢ € ™s
2023-12-13 09:30U:IGCNews ReleaseIGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
2023-12-06 08:30U:IGCNews ReleaseIGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
2023-11-21 08:30U:IGCNews ReleaseIGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
2023-11-13 08:00U:IGCNews ReleaseIGC Pharma Reports Second Quarter Fiscal 2024 Results
2023-10-19 15:30U:IGCNews ReleaseIGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
2023-08-21 14:30U:IGCNews ReleaseIGC Announces Results of its 2023 Annual Stockholders Meeting
2023-08-14 08:30U:IGCNews ReleaseIGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer ¢ € ™s Candidate Through Phase 2 Clinical Trials
2023-08-02 08:30U:IGCNews ReleaseIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
2023-07-18 05:22U:IGCNews ReleaseIGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia at the 2023 Alzheimer ¢ € ™s Association International Conference
2023-07-12 08:44U:IGCNews ReleaseIGC Reports Financial Results for Fiscal Year Ended March 31, 2023
2023-07-07 09:15U:IGCNews ReleaseIGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research
2023-07-06 07:46U:IGCNews ReleaseIGC Pharma Announces a $3 Million Private Placement of its Common Stock
2023-06-05 08:30U:IGCNews ReleaseIGC Pharma ¢ € ™s Advisor and Inventor of Drug Candidate TGR-63 Receives Award
2023-05-18 08:31U:IGCNews ReleaseIGC Pharma to Present at LD Micro Invitational XIII